Abiopharma

Clinical trial NCT07525206: completion date: 2029-05-01 → 2030-03-01.

Clinical trial NCT07220252: start date: 2026-06-01 → 2026-08-01.

Clinical trial NCT06827236 updates: 1. completion date: 2029-05-01 → 2029-08-01 2. primary completion date: 2028-05-01 → 2029-08-01

Clinical trial NCT07138560: primary completion date: 2026-05-15 → 2026-12-15.

Clinical trial NCT06412120 updates: 1. start date: 2026-08-01 → 2026-06-08 2. completion date: 2031-08-01 → 2031-06-08 3. primary completion date: 2029-08-01 → 2029-06-08

Clinical trial NCT03776513 updates: 1. status: UNKNOWN → TERMINATED 2. completion date: 2020-12-12 → 2020-02-19 3. primary completion date: 2020-11-12 → 2020-02-19 4. enrollment: 60 → 30 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07263113 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-01 → 2026-04-10

Clinical trial NCT07545590 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-04-21

Clinical trial NCT06989112 updates: 1. collaborators added: European Network of Gynaecological Oncological Trial Groups (ENGOT) 2. collaborators removed: European Network for Gynaecological Oncological Trial groups(ENGOT)

Clinical trial NCT05441267 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 20000 → 21296 participants 3. enrollment type: ESTIMATED → ACTUAL